New and Emerging Health Technology Reports
Recent Reports from CADTH and Other HTA Agencies
These reports are available without cost at the web sites shown below:
Agence d’évaluation des technologies et des modes d’intervention en santé (AÉTMIS)
- Contribution of BRCA1/2 Mutation Testing to Risk Assessment for Susceptibility to Breast and Ovarian Cancer
- The 13C-urea Breath Test for Detection of Helicobacter Pylori: Potential Applications in Québec
- Telehealth: Clinical Guidelines and Technological Standards for Telepsychiatry (English summary).
Alberta Heritage Foundation for Medical Research (AHFMR)
- Gastric Electrical Stimulation (Enterra™ Therapy system) for the Treatment of Gastroparesis
Canadian Agency for Drugs and Technologies in Health (CADTH)
- CYP450 Genotyping for Determining Drug Metabolizer Status
- BRCA1 and BRCA2 Predictive Genetic Testing for Breast and Ovarian Cancers: A Systematic Review of Clinical Evidence.
- Radiofrequency Ablation in the Treatment of Kidney Cancer
- Intragastric Balloons: A Temporary Treatment for Obesity
Ontario Medical Advisory Secretariat (MAS)
- Coil Embolization for Intracranial Aneurysms: Update
- Air Cleaning Technologies
UK National Institute for Health and Clinical Excellence (NICE)
- Image-guided Vacuum-assisted Excision Biopsy of Benign Breast Lesions [Guidance]
- Mosaicplasty for Knee Cartilage Defects [Guidance]